Ophthalmology News and Research

RSS

Ophthalmology is the specialized field of medicine that focuses on the health of the eye. It includes the anatomy, physiology and diseases that may affect the eye. Historically, the science of ophthalmology encompassed all aspects of visual function, both in health and in illness. Additionally, ophthalmology also includes animal eyes as ocular function and optic diseases are similar among humans and animals.

pSivida's licensee submits NDA to FDA for Iluvien

pSivida Corp., a leader in the development of sustained release back of the eye drug delivery systems for difficult-to-treat conditions, today announced that its licensee, Alimera Sciences has submitted a New Drug Application to the U.S. Food and Drug Administration for Iluvien for Diabetic Macular Edema.

1 Jul 2010

A neuro-optometric rehabilitation case report

The College of Optometrists in Vision Development (COVD) has posted its current issue of Optometry & Vision Development online and invites all to read the full-text articles free of charge.

29 Jun 2010

Scientists discover characteristic amyloid plaques in retinas from Alzheimer's disease patients

The nerve cell-damaging plaque that builds up in the brain with Alzheimer's disease also builds up in the retinas of the eyes - and it shows up there earlier, leading to the prospect that noninvasive optical imaging of the eyes could lead to earlier diagnosis, intervention and monitoring of the disease, according to new research.

25 Jun 2010

Quark Pharmaceuticals' siRNA drug candidates featured in two presentations at Glaucoma & Retinopathies 2010

Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced that two of its siRNA drug candidates were featured in the following two presentations at the Glaucoma & Retinopathies 2010 conference, which was held June 21-22, 2010 in London, UK.

25 Jun 2010

AGTC, Icagen complete agreement for purchase and sale of patent rights

AGTC, a privately held company, and Icagen, Inc. today announced the completion of an agreement for the purchase and sale of certain patent rights between the companies. Icagen is transferring its rights to patents relating to the ion channel gene CNGB3, which has been linked to certain disorders of the eye. Under the terms of the agreement, Icagen has assigned ownership of the patents to AGTC, which intends to use the patented technology for gene therapy as a potential treatment for Achromatopsia, a severe form of daytime blindness.

24 Jun 2010

ACGME task force presents draft standards that revise requirements for better supervision, duty hours

The Accreditation Council for Graduate Medical Education task force charged with reassessing resident training program standards today presented a comprehensive set of draft standards that revise requirements for supervision and duty hours to better match residents' levels of experience and emerging competencies, advancing both graduate medical education and quality patient care in the nation's teaching hospitals.

24 Jun 2010

FDA cancels Advisory Committee review of Lux Biosciences' voclosporin NDA

Isotechnika Pharma Inc. today announced that the U.S. Food and Drug Administration (FDA) has cancelled the Dermatology and Ophthalmology Drugs Advisory Committee review of partner, Lux Biosciences', New Drug Application (NDA) for voclosporin on June 28, 2010.

24 Jun 2010

QLT reports final 24-month results from Phase II RADICAL study in patients with wet AMD

QLT Inc. today announced final 24-month results from the Phase II RADICAL study (Reduced Fluence Visudyne Anti-VEGF-Dexamethasone In Combination for AMD Lesions) in patients with exudative (wet) age-related macular degeneration. The purpose of the study was to determine if Visudyne® combined with Lucentis® reduced retreatment rates compared with Lucentis monotherapy, while maintaining similar vision outcomes and an acceptable safety profile.

22 Jun 2010

OXiGENE reports encouraging data from ZYBRESTAT program at Glaucoma and Retinopathies 2010 conference

OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that the company presented an update on its ZYBRESTAT ophthalmology program, including encouraging preclinical data showing that the company's topical formulation achieved target retina/choroid concentrations with minimal systemic exposure.

22 Jun 2010

Blind cyclists to travel from Toronto to Collingwood in support of the Foundation Fighting Blindness

On Saturday, June 19th, the vision impaired community will team up with cycling enthusiasts to embark on a 140 km journey for second annual Cycle for Sight, in support of the Foundation Fighting Blindness.

19 Jun 2010

National Cheng Kung University Hospital's Outpatient Building inaugurated

The Outpatient Building of National Cheng Kung University Hospital was officially inaugurated on June 12th to provide excellent medical service and to further ensure the health of people in Southern Taiwan.

18 Jun 2010

WTA report card: Many Canadian patients still face long waits for needed medical care

A Wait Time Alliance report card released today reveals troubling wait time hot spots in the five clinical areas deemed priorities by governments and more problems across a broader range of medical care.

18 Jun 2010

UMHHC expects to achieve 3.3% operating margin on revenues of $2.0 billion in fiscal year 2010

The Hospitals and Health Centers unit of the University of Michigan Health System will finish its fiscal year in strong financial shape, with a positive operating margin nearly twice the size predicted a year ago.

18 Jun 2010

Researchers use computer-based model to study human visual intelligence

Scientists have just come several steps closer to understanding change blindness - the well studied failure of humans to detect seemingly obvious changes to scenes around them - with new research that used a computer-based model to predict what types of changes people are more likely to notice.

17 Jun 2010

Lantis Laser to merge with Perio-Imaging

Lantis Laser Inc., announced today that it has signed a Letter of Intent to merge with Perio-Imaging Inc., a private New York based company. The merger would be an all stock transaction and closing, among other conditions, would be subject to raising the required funding to complete the proposed merged company's product development program. The name of the new merged company will be announced upon closing.

16 Jun 2010

Final results from Visudyne Phase IIIb DENALI study presented at World Ophthalmology Congress

QLT Inc. today announced that final results from the Novartis-sponsored Phase IIIb DENALI study were presented on June 8, 2010 during the World Ophthalmology Congress in Berlin. DENALI was a 24-month randomized, double-masked, multicenter trial in patients with subfoveal choroidal neovascularization secondary to wet age-related macular degeneration (all lesion types).

16 Jun 2010

Peter and Patricia Gruber Foundation to present 2010 Neuroscience Prize to Robert H. Wurtz

Robert H. Wurtz, PhD, a pioneer and leader in the field of neurophysiology, is the recipient of the 2010 Neuroscience Prize of The Peter and Patricia Gruber Foundation. His discoveries of how the brain processes visual information and controls eye movements laid the groundwork for subsequent research into the neurophysiology of visual cognition. This research has led scientists to a deeper understanding of how the brain is organized to produce behavior.

15 Jun 2010

Equatorial Guinea advances public health services with ultramodern hospital in Bata

Equatorial Guinea (Republica de Guinea Ecuatorial) is advancing its public health services with an ultramodern hospital in Bata, the country's most populous city. One of the most sophisticated hospitals in West Africa, La Paz Medical Center operates in complete compliance with international standards and employs highly advanced technology systems.

11 Jun 2010

Synteract joins Medidata's ASPire to Win channel partner program

Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today announced that Synteract has joined Medidata's ASPire to Win® channel partner program. A full-service contract research organization (CRO) with an increasing global presence and extensive experience working with emerging biotech, pharmaceutical and medical device sponsors, Synteract will offer services around Medidata Rave®, the market-leading electronic data capture (EDC) and clinical data management (CDM) solution.

9 Jun 2010

Better understanding of eye movements can help develop strategies for reducing crash risks: Study

More than 16 people are killed and more than 1,300 people are injured each day in crashes involving a distracted driver, a phenomenon that could be reduced with the right application of motion information and appropriate eye movements.

9 Jun 2010

Ophthalmology News and Research

Further Reading

pSivida's licensee submits NDA to FDA for Iluvien

A neuro-optometric rehabilitation case report

Scientists discover characteristic amyloid plaques in retinas from Alzheimer's disease patients

Quark Pharmaceuticals' siRNA drug candidates featured in two presentations at Glaucoma & Retinopathies 2010

AGTC, Icagen complete agreement for purchase and sale of patent rights

ACGME task force presents draft standards that revise requirements for better supervision, duty hours

FDA cancels Advisory Committee review of Lux Biosciences' voclosporin NDA

QLT reports final 24-month results from Phase II RADICAL study in patients with wet AMD

OXiGENE reports encouraging data from ZYBRESTAT program at Glaucoma and Retinopathies 2010 conference

Blind cyclists to travel from Toronto to Collingwood in support of the Foundation Fighting Blindness

National Cheng Kung University Hospital's Outpatient Building inaugurated

WTA report card: Many Canadian patients still face long waits for needed medical care

UMHHC expects to achieve 3.3% operating margin on revenues of $2.0 billion in fiscal year 2010

Researchers use computer-based model to study human visual intelligence

Lantis Laser to merge with Perio-Imaging

Final results from Visudyne Phase IIIb DENALI study presented at World Ophthalmology Congress

Peter and Patricia Gruber Foundation to present 2010 Neuroscience Prize to Robert H. Wurtz

Equatorial Guinea advances public health services with ultramodern hospital in Bata

Synteract joins Medidata's ASPire to Win channel partner program

Better understanding of eye movements can help develop strategies for reducing crash risks: Study

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News